Market Overview

FTC Issues Final Approval for IDEXX Labs Consent Agreement

Related IDXX
Canaccord Optimistic On IDEXX Laboratories Catalyst One Rollout
Top Performing Industries For June 24, 2014

IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that the Commissioners of the U.S. Federal Trade Commission ("FTC" or "Commission") have granted final approval of the consent agreement previously reached between the Company and the staff of the FTC Bureau of Competition. The Commission had preliminarily approved the consent agreement in December 2012 and placed the agreement and a proposed draft complaint on public record for comment.

"We are pleased that the Commission has announced final approval of the consent agreement that we reached with the Bureau of Competition staff," said Jonathan Ayers, Chairman and Chief Executive Officer. "While we admit no wrongdoing and continue to believe that our distribution practices did not violate the antitrust laws, this marks final resolution of the multi-year FTC investigation."

Posted-In: News


Most Popular

Related Articles (IDXX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free

Benzinga Professional